用瘤细胞体改变癌症护理:对生物发生,功能作用和治疗潜力的洞察
Popat Mohite1, Rajesh Bogati1, Aishwarya Gorad1
1AET's St. John Institute of Pharmacy and Research, Palghar 401404, Maharashtra, India.
Pharmaceutics
|February 27, 2026
概括
瘤细胞,瘤细胞的大囊泡,对向癌症药物输送有希望. 研究正在探索他们的潜力,尽管在隔离和加载临床使用方面存在挑战.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 细胞外囊泡 细胞外囊泡
背景情况:
- 瘤体是瘤细胞释放的大型细胞外囊泡.
- 它们含有致癌蛋白质,核酸和脂质,促进瘤的传播.
- 在癌症研究中,瘤体正在被研究为潜在的药物输送载体.
研究的目的:
- 审查当前关于瘤体生物发生,组成和癌症进展中的作用的知识.
- 批判性地评价对oncosome隔离,表征和货物装载的方法.
- 讨论在癌症治疗中对工程生体的挑战和未来前景.
主要方法:
- 对临床前研究和现有方法的文献综述.
- 对体生物发生,分子组成和货物运输的分析.
- 对隔离和加载技术 (化,电穿孔,超声波等) 的评估. ) 的情况.
主要成果:
- 胞体具有很大的载荷能力和生物相容性,可用于药物输送.
- 目前的证据主要是来自体外和动物模型的概念验证.
- 重要的挑战包括囊泡异质性,低负载效率和制造约束.
结论:
- 工程瘤体为个性化癌症研究提供了一个有前途的实验平台.
- 解决技术和翻译障碍对于临床应用至关重要.
- 需要进一步的研究来克服大规模生产和安全方面的局限性.
更多相关视频
05:33Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
2.4K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
2.3K
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
15.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.1K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Cancer
55.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.0K
Cancer-Critical Genes I: Proto-oncogenes
11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
